{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T17:32:31Z","timestamp":1772213551732,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.yexcr.2015.06.005","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T17:22:47Z","timestamp":1434734567000},"page":"318-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Expression of the multidrug transporter P-glycoprotein is inversely related to that of apoptosis-associated endogenous TRAIL"],"prefix":"10.1016","volume":"336","author":[{"given":"Paloma S.","family":"Souza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"Madigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Gillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khyati","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh V.","family":"Ambudkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel C.","family":"Maia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Gottesman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"King","family":"Leung Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2015.06.005_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.drup.2012.03.001","article-title":"Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1","volume":"15","author":"Gillet","year":"2012","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.yexcr.2015.06.005_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2015.06.005_bib3","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1007\/s00018-008-8111-5","article-title":"An overview of cancer multidrug resistance: a still unsolved problem","volume":"65","author":"Lage","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.yexcr.2015.06.005_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-60761-416-6_4","article-title":"Mechanisms of multidrug resistance in cancer","volume":"596","author":"Gillet","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.yexcr.2015.06.005_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10428190009060314","article-title":"A role for P-glycoprotein in regulating cell death","volume":"38","author":"Johnstone","year":"2000","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.yexcr.2015.06.005_bib6","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/sj.cdd.4401081","article-title":"P-glycoprotein inhibits caspase-8 activation but not formation of the death inducing signal complex (disc) following Fas ligation","volume":"9","author":"Ruefli","year":"2002","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.yexcr.2015.06.005_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00277-008-0439-2","article-title":"CD34+ leukemic subpopulation predominantly displays lower spontaneous apoptosis and has higher expression levels of Bcl-2 and MDR1 genes than CD34-cells in childhood AML","volume":"87","author":"Shman","year":"2008","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.yexcr.2015.06.005_bib8","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S1470-2045(08)70209-2","article-title":"Targeted manipulation of apoptosis in cancer treatment","volume":"9","author":"Call","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.yexcr.2015.06.005_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","article-title":"Apoptosis: a link between cancer genetics and chemotherapy","volume":"108","author":"Johnstone","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2015.06.005_bib10","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/nrc1736","article-title":"Promoting apoptosis as a strategy for cancer drug discovery","volume":"5","author":"Fesik","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2015.06.005_bib11","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1084\/jem.20122235","article-title":"TRAIL: not just for tumors anymore?","volume":"209","author":"Benedict","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2015.06.005_bib12","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1158\/1078-0432.CCR-10-0631","article-title":"A first-in-human study of conatumumab in adult patients with advanced solid tumors","volume":"16","author":"Herbst","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2015.06.005_bib13","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1111\/bph.12238","article-title":"Death receptors as targets in cancer","volume":"169","author":"Micheau","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.yexcr.2015.06.005_bib14","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/sj.bjc.6605987","article-title":"A Phase 1b\/2 trial of mapatumumab in patients with relapsed\/refractory non-Hodgkin's lymphoma","volume":"103","author":"Younes","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexcr.2015.06.005_bib15","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1006\/cyto.1999.0489","article-title":"Regulation of APO-2 ligand\/trail expression in NK cells-involvement in NK cell-mediated cytotoxicity","volume":"11","author":"Johnsen","year":"1999","journal-title":"Cytokine"},{"key":"10.1016\/j.yexcr.2015.06.005_bib16","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1084\/jem.189.9.1451","article-title":"Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs","volume":"189","author":"Kayagaki","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2015.06.005_bib17","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1158\/0008-5472.CAN-03-1808","article-title":"Neutrophil-derived TNF-related apoptosis-inducing ligand (TRAIL): a novel mechanism of antitumor effect by neutrophils","volume":"64","author":"Koga","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2015.06.005_bib18","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1182\/blood-2003-08-2806","article-title":"IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL\/Apo-2 ligand) displaying apoptotic activity on leukemic cells","volume":"103","author":"Tecchio","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2015.06.005_bib19","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.4049\/jimmunol.168.3.1356","article-title":"Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice","volume":"168","author":"Cretney","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2015.06.005_bib20","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/1521-4141(200208)32:8<2246::AID-IMMU2246>3.0.CO;2-6","article-title":"Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL\/Apo2L, using TRAIL\/Apo2L gene-deficient mice","volume":"32","author":"Sedger","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.yexcr.2015.06.005_bib21","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.leukres.2013.06.014","article-title":"XIAP and P-glycoprotein co-expression is related to imatinib resistance in chronic myeloid leukemia cells","volume":"37","author":"Silva","year":"2013","journal-title":"Leuk. Res."},{"key":"10.1016\/j.yexcr.2015.06.005_bib22","first-page":"925","article-title":"P-glycoprotein and survivin simultaneously regulate vincristine-induced apoptosis in chronic myeloid leukemia cells","volume":"39","author":"Souza","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.yexcr.2015.06.005_bib23","first-page":"3084","article-title":"P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential","volume":"63","author":"Aleman","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2015.06.005_bib24","doi-asserted-by":"crossref","first-page":"18708","DOI":"10.1073\/pnas.1111840108","article-title":"Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance","volume":"108","author":"Gillet","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yexcr.2015.06.005_bib25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/adt.2008.165","article-title":"A dual-fluorescence high-throughput cell line system for probing multidrug resistance","volume":"7","author":"Brimacombe","year":"2009","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.yexcr.2015.06.005_bib26","doi-asserted-by":"crossref","first-page":"32622","DOI":"10.1074\/jbc.M113.498980","article-title":"Mutations in intracellular loops 1 and 3 lead to misfolding of human P-glycoprotein (ABCB1) that can be rescued by cyclosporine A, which reduces its association with chaperone Hsp70","volume":"288","author":"Kapoor","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2015.06.005_bib27","doi-asserted-by":"crossref","first-page":"13989","DOI":"10.1021\/bi026626e","article-title":"Importance of the conserved Walker B glutamate residues, 556 and 1201, for the completion of the catalytic cycle of ATP hydrolysis by human P-glycoprotein (ABCB1)","volume":"41","author":"Sauna","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.yexcr.2015.06.005_bib28","first-page":"18","article-title":"Defeating drug resistance in cancer","volume":"6","author":"Gottesman","year":"2006","journal-title":"Discov. Med."},{"key":"10.1016\/j.yexcr.2015.06.005_bib29","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ajh.20656","article-title":"IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes","volume":"81","author":"Nakagawa","year":"2006","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.yexcr.2015.06.005_bib30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1600-0609.2007.00834.x","article-title":"Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients","volume":"78","author":"Tanaka","year":"2007","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.yexcr.2015.06.005_bib31","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3324\/haematol.2012.070268","article-title":"Dasatinib targets chronic myeloid leukemia-CD34+ progenitors as effectively as it targets mature cells","volume":"98","author":"Hiwase","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.yexcr.2015.06.005_bib32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drup.2012.03.002","article-title":"Collateral sensitivity as a strategy against cancer multidrug resistance","volume":"15","author":"Pluchino","year":"2012","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.yexcr.2015.06.005_bib33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bcp.2006.04.024","article-title":"P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5","volume":"72","author":"Park","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yexcr.2015.06.005_bib34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1476-4598-9-199","article-title":"TRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs\/Akt\/GSK-3beta pathway and activation of caspases","volume":"9","author":"Seo","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2015.06.005_bib35","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bcp.2013.06.004","article-title":"P-glycoprotein-dependent resistance of cancer cells toward the extrinsic TRAIL apoptosis signaling pathway","volume":"86","author":"Galski","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yexcr.2015.06.005_bib36","first-page":"123","article-title":"Playing the DISC: turning on TRAIL death receptor-mediated apoptosis in cancer","volume":"2010","author":"Pennarun","year":"1805","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yexcr.2015.06.005_bib37","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.4161\/cbt.21354","article-title":"Regulation of the human TRAIL gene","volume":"13","author":"Allen","year":"2012","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.yexcr.2015.06.005_bib38","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1007\/s00018-013-1264-x","article-title":"Transcriptional regulation of tumour necrosis factor-related apoptosis-inducing ligand","volume":"70","author":"Azahri","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.yexcr.2015.06.005_bib39","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1006\/bbrc.2000.3872","article-title":"Genomic organization and transcriptional regulation of human Apo2\/TRAIL gene","volume":"278","author":"Gong","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2015.06.005_bib40","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1038\/sj.onc.1202763","article-title":"The antiapoptotic decoy receptor TRID\/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract","volume":"18","author":"Sheikh","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2015.06.005_bib41","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1038\/sj.onc.1206520","article-title":"TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB","volume":"22","author":"Ehrhardt","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2015.06.005_bib42","first-page":"90","article-title":"Selective TRAIL-triggered apoptosis due to overexpression of TRAIL death receptor 5 (DR5) in P-glycoprotein-bearing multidrug resistant CEM\/VBL1000 human leukemia cells","volume":"1","author":"Park","year":"2010","journal-title":"Int. J. Biochem. Mol. Biol."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482715300136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482715300136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T13:50:28Z","timestamp":1617457828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482715300136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0014482715300136"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2015.06.005","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of the multidrug transporter P-glycoprotein is inversely related to that of apoptosis-associated endogenous TRAIL","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2015.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}